A treatment outline for agoraphobia. The Quality Assurance Project.
The Royal Australian and New Zealand College of Psychiatrists has initiated a project to develop treatment outlines for various psychiatric disorders. It is envisaged that the present outline, which was developed by a project team and an expert committee may be modified by the College before being used in post graduate and continuing education and in peer review. In its present form it should be of use to practising psychiatrists. Comments and criticisms on this outline are welcome. A loose-leaf insert is included so that interested readers may respond, either directly to the project team or indirectly via the Editor. This is the first of a series of treatment outlines and concerns the diagnosis and treatment of agoraphobia. The next outline will be on the treatment of depressive illness.
D000379:Agoraphobia / Q000523:psychology / Q000628:therapy*; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D001315:Australia; D001569:Benzodiazepines; D003887:Desensitization, Psychologic / Q000379:methods; D006801:Humans; D006985:Hyperventilation / Q000523:psychology; D009520:New Zealand; D010200:Panic; D010698:Phobic Disorders / Q000628:therapy*; D011369:Professional-Patient Relations; D011785:Quality Assurance, Health Care; D012064:Relaxation Therapy; D012718:Set, Psychology
D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D001569:Benzodiazepines